Park K S, Min K, Nam J H, Bang D, Lee E S, Lee S
Department of Biology, Sungshin Women's University, Seoul, South Korea.
Tissue Antigens. 2005 Mar;65(3):260-5. doi: 10.1111/j.1399-0039.2005.00363.x.
Behcet's disease (BD) is a multisystemic, recurrent inflammatory disease caused by the combinations of multiple genetic and environmental factors. Moreover, the MBL2 gene single-nucleotide polymorphisms and haplotypes are known to increase the susceptibility to inflammatory disease and to alter the serum levels of mannose-binding lectin (MBL. We postulated that the haplotypes of the MBL2 gene influence therapeutic response in BD, thus affecting the clinical symptoms in 282 BD patients. The promoter region, MBL2-550*C/*C (L/L) homozygote was found to have a lower frequency in BD patients than that in controls. No difference was observed in the allele frequencies of G-221C (Y/X), C+4T (P/Q) or Gly54Asp (A/B) of the MBL2 gene in BD patients and in controls. The HYPA haplotype contributed to BD occurrence, whereas the LYPA haplotype was negatively associated with BD. BD patients with several symptoms and with an earlier disease-onset age had a higher HYPA haplotype frequency. BD patients showing poor response (S) to therapy had a higher HYPA frequency than those showing good response (M). It seems that possessing HYPA increases the risk of BD and that the MBL2 HYPA haplotype plays a role in MBL levels and increases the susceptibility to BD.
白塞病(BD)是一种由多种遗传和环境因素共同作用引起的多系统复发性炎症性疾病。此外,已知甘露糖结合凝集素2(MBL2)基因的单核苷酸多态性和单倍型会增加患炎症性疾病的易感性,并改变血清甘露糖结合凝集素(MBL)水平。我们推测MBL2基因的单倍型会影响白塞病的治疗反应,进而影响282例白塞病患者的临床症状。研究发现,MBL2 - 550*C/*C(L/L)纯合子在白塞病患者中的频率低于对照组。在白塞病患者和对照组中,MBL2基因的G - 221C(Y/X)、C + 4T(P/Q)或Gly54Asp(A/B)等位基因频率未观察到差异。HYPA单倍型与白塞病的发生有关,而LYPA单倍型与白塞病呈负相关。有多种症状且发病年龄较早的白塞病患者具有较高的HYPA单倍型频率。治疗反应不佳(S)的白塞病患者的HYPA频率高于治疗反应良好(M)的患者。似乎携带HYPA会增加患白塞病的风险,并且MBL2 HYPA单倍型在MBL水平中起作用并增加对白塞病的易感性。